Track Chair - Targeted potency: Advances in radioligands and bioconjugates
ELRIG Drug Discovery 2026 · 14 October 2026 · 11:15–11:20 · Auditorium 3
Track Chair - Targeted potency: Advances in radioligands and bioconjugates was a session at ELRIG Drug Discovery 2026 on 14 October 2026 in London, with 2 speakers on record.
Speakers
- Nick Tribble — Chair Head Of Antibody Discovery & Protein Sciences, Cancer Research Horizons
- Stuart Haynes — Chair Group Leader, Cancer Reseach Horizons